Serum Lipoproteins and Chronic Periodontitis – A Diagnostic Dilemma

Jump To References Section

Authors

  • H. S. Grover
     Faculty of Dental Sciences, SGT University, Gurgaon, Haryana 122001 ,IN
  • Rohit Saini
     Faculty of Dental Sciences, SGT University, Gurgaon, Haryana 122001 ,IN
  • Shweta Dikshit
     Faculty of Dental Sciences, SGT University, Gurgaon, Haryana 122001 ,IN
  • Anshu Blaggana
     Faculty of Dental Sciences, SGT University, Gurgaon, Haryana 122001 ,IN

Keywords:

Chronic Periodontitis, High-density Lipoprotein (HDL), Low-density Lipoprotein (LDL), Cholesterol, Triglycerides
Oral and Maxillofacial Pathology

Abstract

Objective: To check whether any association can be established between chronic periodontitis and abnormal serum lipoproteins levels.

Methods: A case–control study was designed including 72 subjects (both male and female) falling in the age group of 30–60 years, reporting to the department of periodontology of Faculty of dental sciences; of which, 37 were established as cases, and 35 were identified as controls based on clinical and periodontal parameters. Clinical parameters included serum lipoproteins such as high-density lipoproteins (HDLs), low-density lipoproteins (LDLs), cholesterol, and triglycerides, and the periodontal parameters included clinical attachment level (CAL) and probing pocket depth (PPD).

Results: A statistically significant increase in the incidence of periodontitis was noticed with increasing age (p = 0.05). However, a comparison of gender with incidence of periodontitis failed to reveal significant results (p > 0.087). Statistically significant results were not obtained (p > 0.05), when mean values for each variable viz. HDL, LDL, Cholesterol and TG were compared among cases and controls.

Conclusion: No statistically significant results could be established; as a result, more samples along with controlled confounding factors need to be judged to establish any possible link between chronic periodontitis and abnormal serum lipoprotein levels.

Downloads

Published

2018-09-18

How to Cite

Grover, H. S., Saini, R., Dikshit, S., & Blaggana, A. (2018). Serum Lipoproteins and Chronic Periodontitis – A Diagnostic Dilemma. Journal of Pierre Fauchard Academy (India Section), 29(2-3), 54–58. Retrieved from https://informaticsjournals.co.in/index.php/jpfa/article/view/22269

Issue

Volume 29, Issue 2-3, June - September 2015

Section

Original Articles

License

All the articles published in JPFA are distributed under a creative commons license. The journal allows the author(s) to hold the copyright of their work (all usages allowed except for commercial purpose).

 

References

Stamler J. Research related to risk factors. Circulation. 1979;60:1575–1587.

Nikoskelainen J, Kalliomaki JL, Lapinleimu K, Stenvik M, Halonen PE. Coxsachie B virus antibodies in myocardial infarction. Acta Med Scand. 1983;214:24–32.

Syrjanen J, Valtonen VV, Livanainen M, Kaste M, Huttunen JK. Preceding infection as a major risk for ischaemic brain infarction in young and middle aged patients. Br Med J (Clin Res Ed). 1988;296:1156–1160.

Feingold KR, Staprans I, Memon RA, et al. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res. 1992;33:1765–1776.

Dinarello CA. Interleukin-1 and interleukin 1 antagonism. Blood. 1991;77:1627–1652.

DeStephano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. BMJ. 1993;306:688–691.

Moeintaghavi A, Haerian-Ardakani A, Talebi-Ardakani M, Tabatabaie I. Hyperlipidemia in patients with periodontitis. J Contemp Dent Pract. 2005;6:78–85.

Losche W, Karapetow F, Pohl A, Pohl C, Kocher T. Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J Clin Periodontol. 2000;29:537–541.

Machado AC, Quirino MR, Nascimento LF. Relation between chronic periodontal disease and plasmatic levels of triglycerides, total cholesterol and fractions. Braz Oral Res. 2005;19:284–289.

Valentaviciene G, Paipaliene P, Nedzelskiene I, Zilinskas J, Anuseviciene OV. The relationship between blood serum lipids and periodontal conditions. Stomatologica. 2006;8:96–100.

Brotto RS, Vendramini RC, Brunetti IL, Marcantonio RA, Ramos AP, Pepato MT. Lack of correlation between periodontitis and renal dysfunction in systemically healthy patients. Eur J Dent. 2011;5:8–18.

Taleghani F, Shamaei M, Shamaei M. Association between chronic periodontitis and serum lipid levels. Acta Med Iran. 2010;48:47–50.

Hernichel-Gorbach E, Kornman KS, Hole SC, et al. Host responses in patients with generalized refractory periodontitis. J Periodontol. 1994;65:8–16.

Todd JA. Genetic control autoimmunity in type I diabetes. Immunol Today. 1990;11:122–129.

Morel DW, Dicorleto PE, Chisholm GM. Modulation of endotoxin (LPS-induced) endothelial cell toxicity by low density lipoprotein (LDL). Lab Invest. 1986;55:419–426.

Hadi AR, Carr CS, Suwaidi JL. Endothelial dysfunction: cardiovascular risk factors, therapy and outcomes. Vasc Health Risk Manag. 2005;1:183–198.

Mahdy Ali K, Wonnerth A, Huber K, Wojta J. Cardiovascular disease risk reduction by raising HDL cholesterol – current therapies and future opportunities. Br J Pharmacol. 2012;167:1177–1194.

Kertula Y, Weber TH. Serum lipids in viral and bacterial meningitis. Scand J Infect Dis. 1986;18:211–215.

Li X. Systemic diseases caused by oral infection. Clin Microbiol Rev. 2000;13:547–558.

Rasi V, Ikkala E, Valtonen V. Plasma beta-thromboglobulin in severe infection. Thromb Res. 1982;26:267–274.

Ishida T, Tanaka K. Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture. Atherosclerosis. 1982;44: 161–174.

Semerano N, Lattanzio A. Interaction of platelets and bacterial endotoxins. Agents Actions. 1983;13:461–469.

Stuart MJ. Effect of endotoxin on arachidonic acid release and thromboxane B2 production by human platelets. Am J Hematol. 1981;11:159–164.

Tofter GH, Brezinski D, Schafer AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and cardiac death. N Engl J Med. 1987;316: 1514–1518.

Hujoel PP, Drangsholt M, Spiekerman C, De Roven TA. Periodontitis – systemic disease associations in presence of smoking – causal or coincidental? Periodontol 2000. 2002;30:51–60.

Nishimura F, Takahashi K, Kurihara M, Takashiba S, Murayama Y. Periodontal disease as a complication of diabetes mellitus. Ann Periodontol. 1998;3:20–29.

Liu LS, Spelleken M, Rohrig K, Haunser H, Eckel J. Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the P80 tumor necrosis factor receptor. Diabetes. 1998;47:515–522.

Ylostalo PV, Ek E, Laitinen J, Knuultila ML. Optimism and life satisfaction as determinant for dental and general health behavior-oral health habits linked to cardiovascular risk factors. J Dent Res. 2003;82:194–199.

Katz J, Chaushu G, Sharabi Y. On the association between hypercholesterolemia, cardiovascular disease and severe periodontal disease. J Clin Periodontol. 2001;28:865–868.

Vilkuna-Rautianen T, Pussinen PJ, Roivainen M, et al. Serum antibody response to periodontal pathogens and herpes simplex virus in relation to classic risk factors of cardiovascular disease. Int J Epidemiol. 2006;35:1486–1494.